QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
QQQ   419.50 (-0.92%)
AAPL   165.24 (-1.08%)
MSFT   402.14 (-0.53%)
META   488.94 (-2.56%)
GOOGL   154.88 (-0.72%)
AMZN   176.24 (-1.66%)
TSLA   149.67 (-0.17%)
NVDA   823.50 (-2.74%)
AMD   150.42 (-3.00%)
NIO   3.86 (-3.50%)
BABA   68.88 (+0.00%)
T   16.28 (-0.31%)
F   12.12 (+0.50%)
MU   108.10 (-3.42%)
GE   150.83 (-1.38%)
CGC   7.78 (-0.64%)
DIS   111.89 (-0.48%)
AMC   3.10 (+6.16%)
PFE   25.73 (+1.34%)
PYPL   62.09 (-0.02%)
XOM   120.18 (+1.40%)
Free Trial
ASX:NYR

Nyrada (NYR) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free NYR Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
65,000 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About Nyrada

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurodegenerative diseases. Its products in the drug development stage includes PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; and neuroprotectant drug to reduce the disability in patients with traumatic brain injury and ischaemic stroke. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.

NYR Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive NYR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nyrada and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:NYR
CUSIP
N/A
CIK
N/A
Web
www.nyrada.com
Phone
61 2 9053 1990
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-4,980,000.00
Net Margins
-169.82%
Pretax Margin
N/A
Return on Equity
-72.31%
Return on Assets
-40.53%

Debt

Debt-to-Equity Ratio
10.10
Current Ratio
10.92
Quick Ratio
25.18

Sales & Book Value

Annual Sales
$2.93 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
16.50
Book Value
A$0.03 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
179,410,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.54
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. James Bonnar
    Chief Executive Officer
  • Mr. Cameron Jones C.A.
    Chief Financial Officer
  • Mr. Benjamin Evison Ph.D.
    Chief Scientific Officer
  • Mr. Dimitri Burshtein
    Investor Relations Manager
  • Mr. Mark Waring B.Sc.
    P.M.P., Senior Vice President of US Operations
  • Mr. David James Franks BEc (Age 54)
    C.A., F Fin, J.P., Company Secretary

Key Competitors

View All Competitors

Insiders


This page (ASX:NYR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
My biggest AI fear
Paradigm Press
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing